Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
This study is being done to see if combining liposomal irinotecan with TAS102 and bevacizumab confers clinical benefit for patients with treatment refractory metastatic colorectal cancer.
创建时间：
2023-10-15
